Global Filters




Tiers


Species


Attribution

Filter by Tier
Filter by Species
Filter by Attributions
like "mouse, Ap3m2, alcohol"

Search results are limited to 1000 results out of 1835. Try refining your search.

Returning 1000 results: Page 1 of 40


Tier Species Size Attr. GeneSet
Tier II 17125 GS235061: [MeSH] Amino Acids, Peptides, and Proteins : D000602
Tier II 17084 GS235287: [MeSH] Proteins : D011506
Tier II 15243 GS238990: [MeSH] Mathematical Concepts : D055641
Tier II 17814 GS239769: [MeSH] Gene Library : D015723
Tier II 20142 GS241072: [MeSH] Genetic Phenomena : D055614
Tier II 19954 GS243722: [MeSH] Genetic Structures : D040342
Tier III 26035 GS407934: Differentially expressed genes of post mortem human central Amygdala samples in patients affected by opioid use disorder (OUD) vs. unaffected control samples_qvalue
Tier III 25645 GS407966: Epigenetic alterations identify a confluence of genetic vulnerabilities tied to opioid overdose in humans
Tier IV 3693 GS408178: Differential gene expression comparison between Carnegie Stages (CS) 14 and 17 during human embryo craniofacial development, log2FC
Tier IV 3693 GS408179: Differential gene expression comparison between Carnegie Stages (CS) 14 and 17 during human embryo craniofacial development, Adj-P value
Tier IV 1186 GS408181: Differential gene expression comparison between Carnegie Stages (CS) 15 and 17 during human embryo craniofacial development, Adj-P value
Tier IV 9363 GS408183: Differential gene expression comparison between Carnegie Stages (CS) 15 and 22 during human embryo craniofacial development, Adj-P value
Tier IV 10391 GS408184: Differential gene expression comparison between Carnegie Stages (CS) 13 and 22 during human embryo craniofacial development, log2FC
Tier IV 11875 GS408185: Differential gene expression comparison between Carnegie Stages (CS) 13 and 22 during human embryo craniofacial development, Adj-P value
Tier IV 11651 GS408190: Differential gene expression comparison between Carnegie Stages (CS) 14 and 22 during human embryo craniofacial development, Adj-P value
Tier IV 8709 GS391: RIKEN Cerebellum C57BL/6J Development Series
Tier III 105 GS799: UCSD_CEREBELLUM_Add_Cubic
Tier III 898 GS863: Differential expression across development in Sey Pax6 mutants and controls in an inverted-U (downward parabola).
Tier II 42 GS33913: Whole Brain Gene expression correlates of Distance traveled (cm) during the third five minute bin after saline in Females BXD
Tier II 29 GS33923: Whole Brain Gene expression correlates of Distance traveled (cm) during the fourth five minute bin after ethanol in Females BXD
Tier II 64 GS33944: Whole Brain Gene expression correlates of Morphine distance (cm) travelled minutes 120-135 in Females & Males BXD
Tier II 66 GS33959: Whole Brain Gene expression correlates of Morphine distance (cm) travelled minutes 150-165 in Females & Males BXD
Tier II 60 GS33968: Whole Brain Gene expression correlates of Morphine distance (cm) travelled minutes 165-180 in Males BXD
Tier II 61 GS34226: Striatum Gene expression correlates of Light-Dark Box Percentage of distance traveled in light compartment in Females BXD
Tier II 47 GS34236: Striatum Gene expression correlates of Light-Dark Box Percentage time in light in Females BXD